knowledge -WSS

knowledge

author：fashion 2025-09-29 17:56:49 Page View：89839

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Study suggests new cause of Down syndrome: cells linked to aging
Next article： Psychedelics group wrestles with new pharma identity

explore

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Merck to acquire Harpoon Therapeutics for $680 million

MelEvans/APMerckannouncedMondayitwillacquireHarpoonTherapeuticsanditspipelineofimmune-basedcancerdru

23andMe had bad news about my health. I wish a person had delivered it

ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

Ascension's ugly legal battle over care for poor patients in Texas

Austin,Texashasbecomethegroundsforduelingpowerfulinterestsfightingoverhealthcareservicesforpoorpatie

knowledge

Wikipedia

explore

Ascension's ugly legal battle over care for poor patients in Texas